Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in other markets

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330. The price hike is not directly related to the US MFN order, despite coinciding with international drug pricing discussions. Weight-loss medication in the UK is going to make both people and their wallets lighter.